Skip to main content


Fig. 3 | Journal of Translational Medicine

Fig. 3

From: In vivo evidence of ascorbate involvement in the generation of epigenetic DNA modifications in leukocytes from patients with colorectal carcinoma, benign adenoma and inflammatory bowel disease

Fig. 3

Expression of TET1 (a), TET2 (b) and TET3 (c) mRNA in healthy controls (n = 79) and patients with inflammatory bowel disease (IBD, n = 51), adenomatous polyps (n = 67) and colorectal cancer (n = 136). The results presented as medians, interquartile ranges and non-outlier ranges. Normalized values were subjected to one-way analysis of variance (ANOVA) with LSD and Tukey post hoc tests

Back to article page